Arbe Robotics Ltd. Announces $15 Million Underwritten Registered Direct Offering

The financing would provide funds for operations and possible acquisitions, while the warrants could add ordinary shares.

Rhea-AI Summary

Arbe Robotics (ARBE) priced an underwritten registered direct offering expected to raise approximately $15 million before expenses on September 25, 2026.

Arbe is offering 833,334 ordinary shares at $0.60 per share and pre-funded warrants to purchase up to 24,166,666 ordinary shares at $0.5999 per warrant. The offering is expected to close on or about September 28, 2026, subject to customary closing conditions. Arbe intends to use the net proceeds for working capital and general corporate purposes, including scaling operations, its intended expansion into defense and counter-drone markets, and potentially pursuing merger and acquisition opportunities.

Positive

• Approximately $15 million in gross proceeds expected before expenses

Negative

• Warrants could add up to 24,166,666 ordinary shares

News Explained

Upon closing, Arbe receives gross proceeds, while new ordinary shares and later warrant exercise can reduce existing holders’ percentage ownership.

Arbe has priced a company-issued registered direct offering, with closing expected on or about September 28, 2026, subject to customary conditions; it estimates $15 million in gross proceeds before expenses. If it closes, Arbe sells 833,334 ordinary shares and warrants for up to 24,166,666 shares; ordinary shares issue at closing, while warrant shares issue only upon exercise, and either issuance increases the share count and reduces existing holders’ percentage ownership.

A pre-funded warrant is sold at nearly the share price with a nominal exercise price and converts into shares upon exercise; here, the $0.0001 exercise-price warrants are immediately exercisable and have no expiry until exercised in full.

At the last reported operating cash-use rate in the fourth quarter of 2025, the $15 million gross offering equals 153.1 days of that historical outflow. Reported cash and short-term investments as of December 31, 2025 equal 456.4 days of operating cash use at that same rate.

Arbe says a final prospectus supplement will be filed; that document sets final offering terms, including fees, and is the named filing to check for the final amount after expenses.

Sources and calculations

• Arbe Robotics offering announcement (2026-09-25)
• Arbe Robotics 2025 fourth-quarter fundamentals (2025Q4)
• Dilution definition (2026-07-17)
• Pre-funded warrant definition (2026-07-17)
• Prospectus supplement purpose (2026-07-17)

• Offering gross against the last reported quarterly operating outflow, in days at that rate $15,000,000 / ($9,015,000 / 92) = 153.1 days
• Available liquidity against the last reported quarterly operating outflow, in days at that rate ($4,028,000 + $40,690,000) / ($9,015,000 / 92) = 456.4 days

Argus 15 min delay 6 alerts

-14.20% vs previous close $0.58 last price 5.6x rel. volume Open Argus

Details

Market move: ARBE -14.20% vs previous close. registered direct offering

-22.0% Trough in 0 min

$0.50 $0.71 Day Range

$73.45M Market Cap

On Sep 25, the day this news came out, the latest delayed price for ARBE is 14.20% below the previous close. Argus tracked a trough of -22.0% from its starting point during tracking. Our momentum scanner has recorded 6 alerts for this stock so far that day. The latest delayed price is $0.58. Relative volume is exceptionally heavy at 5.6x the average.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Market Context

Arbe's January 26, 2026 registered direct offering recorded a 17.06% negative 24-hour reaction in th...

Analysis

Arbe's January 26, 2026 registered direct offering recorded a 17.06% negative 24-hour reaction in the historical data, making that prior financing a format-matched reference, not evidence about this offering's trading response.

Key Figures

Ordinary shares offered: 833,334 shares Ordinary share purchase price: $0.60 per share Pre-funded warrants: Up to 24,166,666 ordinary shares +4 more

Ordinary shares offered

833,334 shares

Priced at $0.60 per share

Ordinary share purchase price

$0.60 per share

Offering price

Pre-funded warrants

Up to 24,166,666 ordinary shares

Underlying shares issuable upon exercise

Pre-funded warrant purchase price

$0.5999 per share

In lieu of ordinary shares for certain investors

Pre-funded warrant exercise price

$0.0001 per share

Warrants are immediately exercisable

Estimated gross proceeds

Approximately $15 million

Before underwriting discounts, commissions, and other offering expenses

Expected offering close

On or about September 28, 2026

Subject to customary closing conditions

Previous Offering Reports

2 past events · Latest: Jan 26

Same Type 2 events

1. Jan 26

   Registered direct offering

   24h Move

   -17.1%

   Priced 11.5 million ordinary shares at $1.40, estimating $16.1 million gross proceeds.

2. Jan 07

   Registered direct offering

   24h Move

   -6.0%

   Priced 8,984,375 ordinary shares at $3.20 in a $29 million direct offering.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

underwritten registered direct offering, pre-funded warrants, form f-3, prospectus supplement

4 terms

underwritten registered direct offering financial

"priced an underwritten registered direct offering of 833,334 ordinary shares"

An underwritten registered direct offering is a way a company raises money by selling newly registered shares or bonds directly to selected investors, with an investment bank agreeing to buy and resell the securities so the company knows it will receive the cash. Think of the bank as a wholesaler that guarantees to take the inventory and find buyers; it speeds the sale but often means the securities are sold at a discount, which can dilute existing shareholders and affect the stock price.

pre-funded warrants financial

"pre-funded warrants to purchase up to 24,166,666 ordinary shares"

Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.

form f-3 regulatory

"offered pursuant to a registration statement on Form F-3"

Form F-3 is a U.S. securities filing that lets eligible foreign companies pre-register and then quickly sell shares or other securities to raise money, because they already meet ongoing reporting and size tests. For investors it signals that the company is up-to-date with regulatory disclosure and has an efficient way to issue new securities — similar to a pre-approved credit line — which can mean faster capital raises but also potential dilution of existing holdings.

prospectus supplement regulatory

"a prospectus and a prospectus supplement which forms a part"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

TEL AVIV, ISRAEL, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Arbe Robotics Ltd. (NASDAQ: ARBE), (TASE: ARBE) (“Arbe” or the “Company”), a global leader in ultra-high-resolution radar solutions, today announced that it has priced an underwritten registered direct offering of 833,334 ordinary shares at a purchase price of $0.60 per share and, in lieu of ordinary shares to certain investors, pre-funded warrants to purchase up to 24,166,666 ordinary shares at a purchase price of $0.5999 per share, which equals the offering price per ordinary share less the $0.0001 exercise price per share of each pre-funded warrant. The pre-funded warrants are immediately exercisable and will not expire until exercised in full. All ordinary shares and pre-funded warrants to be sold in the offering will be offered by the Company.

Arbe estimates the gross proceeds from this offering to be approximately $15 million before deducting underwriting discounts and commissions and other offering expenses. The offering is expected to close on or about September 28, 2026, subject to the satisfaction of customary closing conditions. Arbe intends to use the net proceeds from this offering for working capital and general corporate purposes, including, but not limited to, scaling its operations to support growing commercial opportunities, including the recently announced selection of Arbe’s radar technology for an L3 passenger vehicle program of one of the world’s largest automotive groups and its intended expansion into the defense and counter-drone markets, as well as to potentially pursue potential strategic merger and acquisition opportunities.

Canaccord Genuity is acting as sole bookrunner for the offering.

The securities described above are being offered pursuant to a registration statement on Form F-3 (File No. 333-287805), originally filed on June 5, 2025, with the Securities and Exchange Commission (the “SEC”) and declared effective by the SEC on June 13, 2025. The offering is being made only by means of a prospectus and a prospectus supplement which forms a part of the effective registration statement relating to the offering. A final prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC. Electronic copies of the final prospectus supplement, when available, may be obtained on the SEC’s website at http://www.sec.gov and may also be obtained, when available, by contacting Canaccord Genuity LLC, Attn: Syndication Department, 1 Post Office Square, 30th Floor, Boston, MA 02109, or by email at prospectus@cgf.com.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Arbe Robotics Ltd.

Arbe (NASDAQ: ARBE), a global leader in ultra-high-resolution radar solutions, is redefining radar as a core sensing platform for next-generation mobility and defense. Arbe's complete radar technology stack, from proprietary chipsets to radar systems and AI algorithms that produce perception-ready data, delivers the detail and real-time processing that demanding sensing applications require. Arbe enables OEMs, Tier-1s, and defense integrators to build more capable perception systems for passenger vehicles, robotaxis, heavy machinery, and counter-drone systems.
Headquartered in Tel Aviv, Israel, Arbe also operates offices in the United States, Germany, and China. For more information, visit https://arberobotics.com/ 

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, both as amended by the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the expected timing, completion or size of the offering, the expected gross proceeds therefrom, and the intended use of net proceeds therefrom. The words "expect," "believe," "estimate," "intend," "plan," "anticipate," "may," "should," "strategy," "future," "will," "project," "potential" and similar expressions indicate forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. These risks and uncertainties include the possible delisting of the Company's ordinary shares from Nasdaq in the event the bid price per share of the Company's ordinary shares remains below $1.00, the effect on the Israeli economy generally and on the Company's business resulting from the terrorism and the hostilities in Israel, including the continuing hostilities with Iran, Hezbollah and Hamas and any intensification of hostilities, and the effect of the call-up of a significant portion of its working population, including the Company's employees, the ability of the Company to develop and market the Alerion radar system and deliver units in a timely and profitable manner, the ability of the Alerion radar system to operate as planned under wartime conditions, and the risks and uncertainties described in "Cautionary Note Regarding Forward-Looking Statements," "Item 3. Key Information – D. Risk Factors" and "Item 5. Operating and Financial Review and Prospects" and in the Company's Annual Report on Form 20-F for the year ended December 31, 2025, which was filed with the Securities and Exchange Commission (the "SEC") on March 27, 2026, as well as other documents filed by the Company with the SEC. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements relate only to the date they were made, and the Company does not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made except as required by law or applicable regulation. Information contained on, or that can be accessed through, the Company's website or any other website or any social media is expressly not incorporated by reference into and is not a part of this press release.

Investor Relations:

Ehud Helft & Kenny Green

EK Global Investor Relations

investors@arberobotics.com

+1 212 378 8040

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Arbe Robotics' registered direct offering expected to close?

The offering is expected to close on or about September 28, 2026, subject to customary closing conditions.

When can investors exercise the pre-funded warrants in Arbe Robotics' offering?

The pre-funded warrants are immediately exercisable and do not expire until exercised in full. Each warrant has an exercise price of $0.0001 per share.